Gufic Biosciences Ltd vs Jagsonpal Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 14, 2026

Key Highlights

The Latest Trading Price of Gufic BioSciences Ltd is ₹ 371.3 as of 12 Jun 15:30 . The P/E Ratio of Gufic BioSciences Ltd is 33 as of March 2024 .The P/E Ratio of Jagsonpal Pharmaceuticals Ltd is 0 as of March 2024 . The Market Cap of Gufic BioSciences Ltd is ₹ 2839 crore as of March 2024 .The Market Cap of Jagsonpal Pharmaceuticals Ltd is ₹ 0 crore as of March 2024 . The revenue of Gufic BioSciences Ltd for the Mar '26 is ₹ 250.65 crore as compare to the Dec '25 revenue of ₹ 232.2 crore. This represent the growth of 7.95% The revenue of Jagsonpal Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Gufic BioSciences Ltd for the Mar '26 is ₹ 46.04 crore as compare to the Dec '25 ebitda of ₹ 33.77 crore. This represent the growth of 36.33% The ebitda of Jagsonpal Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Gufic BioSciences Ltd changed from ₹ 20.86 crore to ₹ 21.9 crore over 8 quarters. This represents a CAGR of 2.46% The net profit of Jagsonpal Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The Dividend Payout of Gufic BioSciences Ltd changed from 2.19 % on March 2021 to 1.43 % on March 2025 . This represents a CAGR of -8.17% over 5 yearsThe Dividend Payout of Jagsonpal Pharmaceuticals Ltd changed from 15.36 % on March 2021 to 29.99 % on March 2025 . This represents a CAGR of 14.32% over 5 years .

About Gufic BioSciences Ltd

Gufic Biosciences Limited is a prominent global pharmaceutical enterprise dedicated to delivering a broad spectrum of pharmaceutical services to its clients.
Renowned for its extensive range of pharmaceutical products, Gufic operates as a comprehensive solution provider in both domestic and international markets, supported by a robust distribution network.
The Company is ranked among the top 100 pharmaceutical companies in India. Gufic is a leading manufacturer of lyophilized injections in India, with a state-of-the-art automated lyophilization plant located in Navsari, Gujarat.
The Company was incorporated in July, 1984.
The recent addition of the Indore manufacturing facility has further solidified Gufic's position as one of the world's largest producers of lyophilized injections.

About Jagsonpal Pharmaceuticals Ltd

Promoted by Rajpal Singh Kochhar in August, 1978, Jagsonpal Pharmaceuticals Limited is engaged in the manufacture and marketing bulk drugs and pharmaceuticals at its plant at Faridabad in Haryana.
The Company has adopted the strategy of clubbing all its products in seven groups for effective marketing and reducing costs.
Simultaneously, it has geared up to set up an ultra modern multi-purpose basic drugs and formulation plant through its subsidiary, Jagsonpal Exports India Pvt Ltd. The company has a strategic alliance with Fidia Spa, Italy; and B Spofola, Czechoslovakia; to manufacture sophisticated drugs in India.
It has tied up with another Israel-based company, Makhteshim Chemical Works, for acquiring the marketing rights of an anti-oxidant product.
In 1994, the company has also promoted Aresco Financial Services, a new financial company.

FAQs for the comparison of Gufic BioSciences Ltd and Jagsonpal Pharmaceuticals Ltd

Which company has a larger market capitalization, Gufic BioSciences Ltd or Jagsonpal Pharmaceuticals Ltd?

Market cap of Gufic BioSciences Ltd is 3,723 Cr while Market cap of Jagsonpal Pharmaceuticals Ltd is 1,387 Cr

What are the key factors driving the stock performance of Gufic BioSciences Ltd and Jagsonpal Pharmaceuticals Ltd?

The stock performance of Gufic BioSciences Ltd and Jagsonpal Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Gufic BioSciences Ltd and Jagsonpal Pharmaceuticals Ltd?

As of June 14, 2026, the Gufic BioSciences Ltd stock price is INR ₹371.3. On the other hand, Jagsonpal Pharmaceuticals Ltd stock price is INR ₹210.8.

How do dividend payouts of Gufic BioSciences Ltd and Jagsonpal Pharmaceuticals Ltd compare?

To compare the dividend payouts of Gufic BioSciences Ltd and Jagsonpal Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.